Reducing the burden of diabetes treatment: A review of low-cost oral hypoglycemic medications

Keyphrases

• Diabetes Management 100%
• Pioglitazone 100%
• Oral Hypoglycemic Agents 100%
• Diabetes Burden 100%
• Sulfonylurea 83%
• Glimepiride 66%
• Metformin 66%
• Glyburide 50%
• Extended Release 50%
• Intermediate Release 50%
• Non-associated 33%
• Adverse Events 33%
• Time to Peak 33%
• HbA1c Levels 33%
• Glipizide 33%
• Diabetes 16%
• RelA 16%
• Weight Gain 16%
• Cardiovascular Events 16%
• Hypoglycemia 16%
• Daily Dose 16%
• Renal Impairment 16%
• Narrative Review 16%
• Low-middle Income 16%
• Potential Adverse Events 16%
• Adverse Events Profile 16%
• Cardiovascular Event Rates 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidiabetic Agent 100%
• Pioglitazone 100%
• Sulfonylurea 83%
• Adverse Event 66%
• Glimepiride 66%
• Metformin 66%
• Glibenclamide 50%
• Hemoglobin A1c 33%
• Glipizide 33%
• Carisoprodol 16%
• Hypoglycemia 16%